Changes in Serum Interferon Gamma and Interleukin-10 in Relation to Direct-Acting Antiviral Therapy of Chronic Hepatitis C Genotype 4: A Pilot Study.
J Clin Exp Hepatol
; 12(2): 428-434, 2022.
Article
en En
| MEDLINE
| ID: mdl-35535108
ALT, alanine transaminase; AST, aspartate transaminase; CHC, chronic hepatitis c; DAA, Direct-acting antivirals; DAC, daclatasvir; DM, diabetes melliteus; EDTA, ethylenediaminetetraacetic acid; HCV, Hepatitis C virus; HTN, systemic hypertension; IFN-γ, interferon gamma; IL-10, interleukin 10; INR, international normalized ratio; NCCVH, National Committee for Control of Viral Hepatitis; SOF, sofosbuvir; STROBE, strengthening the reporting of observational studies in epidemiology; SVR, sustained virological response rates; Th, T-helper; cytokines; direct-acting antivirals; hepatitis C virus; interferon gamma; interleukin-10
Texto completo:
1
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Plantas_medicinales
Idioma:
En
Revista:
J Clin Exp Hepatol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Egipto